Stage III Ovarian Cancer AJCC v6 and v7 Recruiting Phase 2 Trials for Paclitaxel (DB01229)

Indication	Status	Phase
DBCOND0093245 (Stage III Ovarian Cancer AJCC v6 and v7)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02520154	Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	Treatment	Carbocisteine (DB04339) Carboplatin (DB00958) Paclitaxel (DB01229) Pembrolizumab (DB09037)